[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![teambullish95 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1651073071.png) Jones [@teambullish95](/creator/twitter/teambullish95) on x XXX followers
Created: 2025-07-18 03:34:42 UTC

$MESO PR here Mesoblast Reports $13.2M in Q2 Ryoncil® Launch Revenue, $1.6M in TEMCELL® Royalties

 Mesoblast posted $13.2M in unaudited Q2 revenue from Ryoncil® sales following its March XX U.S. launch. Ryoncil is the first FDA-approved MSC therapy for pediatric SR-aGvHD.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946050973689946157/c:line.svg)

**Related Topics**
[$16m](/topic/$16m)
[$132m](/topic/$132m)
[$meso](/topic/$meso)

[Post Link](https://x.com/teambullish95/status/1946050973689946157)